Daniel Patrick O'Day - 10 Jun 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chairman & CEO, Director
Signature: /s/ Edward S. Son by Power of Attorney for Daniel P. O'Day
Issuer symbol: GILD
Transactions as of: 10 Jun 2022
Net transactions value: -$93,479
Form type: 4
Filing time: 13 Jun 2022, 19:59:10 UTC
Previous filing: 14 Mar 2022
Next filing: 12 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+3,300	+1.3%		252,644	10 Jun 2022	Direct	F1
transaction	GILD	Common Stock	Tax liability	$93,479	-1,539	-0.61%	$60.74	251,105	10 Jun 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-3,300	-2.4%		134,014	10 Jun 2022	Common Stock	3,300		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.